Inari Medical Inc. logo

Inari Medical Inc. (NARI)

Delisted
19 Feb 2025
NASDAQ (NGS) NASDAQ (NGS)
$
79. 97
0
0%
$
2.24B Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.56 Eps
$ 79.97
Previous Close
Investors:
Day Range
79.97 79.97
Year Range
36.73 79.99
Want to track NARI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
July 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NARI

July 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NARI

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI

INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI

NEW ORLEANS, LA / ACCESSWIRE / June 6, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 12, 2024 to file lead plaintiff applications in a securities class action lawsuit against Inari Medical, Inc. (NasdaqGS:NARI), if they purchased the Company's shares between February 24, 2022 and February 28, 2024, inclusive (the "Class Period").

Accesswire | 2 years ago
Contact Levi & Korsinsky by July 12, 2024 Deadline to Join Class Action Against Inari Medical, Inc. (NARI)

Contact Levi & Korsinsky by July 12, 2024 Deadline to Join Class Action Against Inari Medical, Inc. (NARI)

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
The Schall Law Firm Has Initiated An Investigation And Is Encouraging Investors Who Have Suffered Losses In Inari Medical, Inc. To Reach Out To Them

The Schall Law Firm Has Initiated An Investigation And Is Encouraging Investors Who Have Suffered Losses In Inari Medical, Inc. To Reach Out To Them

LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.

Accesswire | 2 years ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical Lawsuit - NARI

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical Lawsuit - NARI

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Investors Who Lost Money on Inari Medical, Inc.(NARI) Should Contact Levi & Korsinsky About Pending Class Action - NARI

Investors Who Lost Money on Inari Medical, Inc.(NARI) Should Contact Levi & Korsinsky About Pending Class Action - NARI

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
The Schall Law Firm Is Urging Investors Who Have Incurred Losses In Inari Medical, Inc. To Contact Them. Please Be Mindful Of The Deadline In This Matter

The Schall Law Firm Is Urging Investors Who Have Incurred Losses In Inari Medical, Inc. To Contact Them. Please Be Mindful Of The Deadline In This Matter

LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.

Accesswire | 2 years ago
Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Class Action Filed Against Inari Medical, Inc. (NARI) - July 12, 2024 Deadline to Join – Contact Levi & Korsinsky

Class Action Filed Against Inari Medical, Inc. (NARI) - July 12, 2024 Deadline to Join – Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Class Action Filed Against Inari Medical, Inc. (NARI) - July 12, 2024 Deadline to Join - Contact Levi & Korsinsky

Class Action Filed Against Inari Medical, Inc. (NARI) - July 12, 2024 Deadline to Join - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 2 years ago
Inari Medical Faces Lengthy DOJ Probe and Investor Suit Over Potential Kickbacks to Doctors– Hagens Berman

Inari Medical Faces Lengthy DOJ Probe and Investor Suit Over Potential Kickbacks to Doctors– Hagens Berman

Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm SAN FRANCISCO, CA / ACCESSWIRE / June 5, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: [email protected] 844-916-0895 Inari Medical, Inc. (NARI) Class Action: Inari Medical, a medical device manufacturer, is bracing for a protracted investigation by the Department of Justice (DOJ) centering on allegations of illegal kickbacks to healthcare professionals.

Accesswire | 2 years ago
Loading...
Load More